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Atrialfibrillation (AF), themost prevalent sustained cardiac arrhyth-
mia, often coexists with the related arrhythmia atrial flutter (AFL).
Limitations in effectiveness and safety of current therapiesmake an
understanding of the molecular mechanism underlying AF more
urgent. Genome-wide association studies implicated a region of
human chromosome 4q25 in familial AF and AFL, ≈150 kb distal to
the Pitx2 homeobox gene, a developmental left–right asymmetry
(LRA) gene. To investigate the significance of the 4q25 variants, we
used mouse models to investigate Pitx2 in atrial arrhythmogenesis
directly. When challenged by programmed stimulation, Pitx2null+/−
adult mice had atrial arrhythmias, including AFL and atrial tachycar-
dia, indicating that Pitx2 haploinsufficiency predisposes to atrial
arrhythmias. Microarray and in situ studies indicated that Pitx2
suppresses sinoatrial node (SAN)-specific gene expression, includ-
ing Shox2, in the left atrium of embryos and young adults. In vivo
ChIP and transfection experiments indicated that Pitx2 directly
boundShox2 in vivo, supporting thenotion that Pitx2directly inhib-
its the SAN-specific genetic program in left atrium. Our findings
implicate Pitx2 and Pitx2-mediated LRA-signaling pathways in
prevention of atrial arrhythmias.
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Atrial fibrillation (AF), the most common adult arrhythmia,increases in prevalence with age, eventually afflicting 5% of
the population over age 65 years and 10% of those over age 80
years. Moreover, patients with AF have a significantly increased
risk of stroke, heart failure, and dementia (1–3). Electrical
impulses critical for a normal heartbeat are initiated in the sino-
atrial node (SAN) or pacemaker region. In AF, rapid and irreg-
ular atrial activity overrides normal SAN function, often resulting
in irregular impulse conduction to the ventricles. In many cases,
ectopic electrical activity originates in the pulmonary veins and
may serve to trigger and maintain AF (1, 4). The related ar-
rhythmia, atrial flutter (AFL), displays more regular and orga-
nized electrical activity than does AF (5). Significantly, current
treatments for AF are suboptimal because of incomplete effec-
tiveness and deleterious side effects. It also has been recognized
that untreated AF results in pathologic remodeling that makes AF
more likely to recur (6). Thus, it is critically important to uncover
the genetic mechanisms underlying AF to aid in patient man-
agement and to develop more safe and effective therapies.
The pituitary homeobox (Pitx) family of homeobox genes con-
taining three genes, Pitx1, Pitx2, and Pitx3, is a subgroup within the
larger Paired-related superfamily of homeobox genes (7, 8). Pitx2
was identified as the gene mutated in Rieger syndrome I, a hap-
loinsufficient disorder that includes ocular, tooth, and anterior
body wall defects as primary characteristics (9). Importantly, the
Pitx2 gene encodes three isoforms: Pitx2a, Pitx2b, and Pitx2c. The
Pitx2c isoform plays a critical role as a late effector in left–right
asymmetry (LRA), a fundamental component of organ morpho-
genesis in vertebrates. The signaling pathways regulating LRA are
initiated in the presomite-stage embryo and are mediated in large
part through Nodal signaling. Pitx2c is the major downstream
effector of the Nodal pathway (10).
Recent genome-wide association studies identified sequence
variants on chromosome 4q25 that were associated with in-
creased risk for AF in multiple human populations (11–13).
Moreover, the 4q25 variants were strongly associated with AF
cases diagnosed at an earlier age (<60 years) and with recurrence
after ablation therapy (14). In a small Icelandic cohort, the se-
quence variants also were strongly associated with AFL (11).
These correlative sequence variants were found in proximity to
Pitx2, suggesting that Pitx2 may be the AF locus in this region.
We show that Pitx2c is expressed in the immediate postnatal
period in left atrium and pulmonary vein. Moreover, Pitx2null+/−
mice that are heterozygous for a Pitx2-null allele that removes all
isoform function (15) are prone to atrial arrhythmias. In vivo
ChIP assays reveal that Pitx2c binds directly to Shox2, suggesting
that Pitx2c directly represses the SAN genetic program in the left
atrium. Together, our findings support Pitx2 as a bona fide sus-
ceptibility gene for atrial arrhythmias.
Results
Pitx2c Is Expressed in the Postnatal Left Atrium and Pulmonary Vein.
To determine if Pitx2 is expressed in the postnatal heart, we
generated a Pitx2 LacZ knockin allele, Pitx2LacZ, to follow Pitx2
expression efficiently (Methods). LacZ staining in postnatal day 3
(P3) pups indicated that Pitx2 was expressed in the left atrium and
pulmonary veins (Fig. 1 A–C). Sections confirmed that Pitx2LacZ
directed LacZ activity in the left atrium and pulmonary veins (Fig.
1 D–G). Pitx2 expression also was detected in the right ventricle,
although this expression was weak (Fig. 1B). By P42, Pitx2 ex-
pression was detected in the left atrial myocardium, although at
diminished levels (Fig. 1 H–J). At 1 year, Pitx2 expression was
found only in rare left atrial myocardial cells (Fig. 1 K–N). To gain
insight into postnatal Pitx2 isoform expression, we investigated
LacZ expression in a transgenic line, Pitx2ctg3K, in which LacZ is
directed by Pitx2c regulatory elements (16). Because this Pitx2c
transgene is influenced by copy number and position effect, this
experiment provided only qualitative information about Pitx2
isoform expression in left atrium. In 3-month-old Pitx2ctg3K
transgenic mice, we found LacZ activity in right ventricle and left
atrium, supporting the notion that Pitx2c was expressed in the
postnatal left atrium and right ventricle (Fig. S1 A–D). RT-PCR
experiments also indicated that Pitx2c was expressed in left atrium
(Fig. 1O). Quantitative RT-PCR indicated that Pitx2c expression
levels in a 3-month-old left atrium were≈25% of that found in the
embryo 13.5 days postconception (dpc) (Fig. 1P). Together, these
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findings indicate that Pitx2c is expressed in postnatal left atrium,
pulmonary vein, and right ventricle and that Pitx2c expression in
left atrium is silenced during aging.
Baseline Electrophysiological Features of Pitx2null+/− Mice. To test
the hypothesis that Pitx2c is a susceptibility gene for atrial
arrhythmias such as AF and AFL, we first used conventional six-
lead surface ECG and four-lead bipolar intracardiac electro-
grams to record simultaneously in WT and Pitx2null+/− mice (Fig.
S2). Under baseline conditions, there were no differences be-
tween Pitx2null+/− and WT mice in heart rate, interval between
two consecutive R wave peaks (RR), interval from beginning of
the P wave to the peak of the R wave (PR), or in the time
elapsing from the beginning of the QRS complex to the end of
the T wave (corrected Q-T interval) on surface ECGs (Table 1),
with the exception of a small but significant prolongation of the
QRS interval in Pitx2null+/− mice. These findings were corrobo-
rated using bipolar intracardiac electrogram recordings. Endo-
cardial programmed electrical stimulation was used to determine
atrial effective refractory period, atrioventricular nodal effective
refractory period, and sinus node recovery time at a basic cycle
length of 100 ms. There were no significant differences between
Pitx2null+/− and WT mice (Table 1). During these electrophysi-
ological studies, no episodes of spontaneous AF were observed
in any of the mice studied.
Pacing-Induced Atrial Arrhythmias in Pitx2null+/− Mice. Although
Pitx2null+/− mice were in normal sinus rhythm at baseline, we
wanted to test the notion that Pitx2c haploinsufficiency predis-
posed mice to atrial arrhythmias. There is precedent for this
idea, because a mouse model for a gain-of-function mutation in
ryanodine receptor type II (RyR2) provided a substrate for AF
that was insufficient to produce spontaneous arrhythmias. RyR2
mutants required a second arrhythmogenic triggering event, in
this case activation of Ca2+/calmodulin-dependent protein ki-
nase II, which was uncovered by increased heart rate (17).
Inducibility of atrial arrhythmias, determined twice in each
mouse, was measured with surface leads and an intraatrial
catheter using the stimulation protocol previously described (17,
18). Episodes of AFL/tachycardia, defined as rapid but regular
atrial rhythm lasting >1,000 ms (19), were observed frequently in
Pitx2null+/− mice (Fig. 2 A–C). Based on a-wave morphology and
rate on the atrial electrogram, episodes of pacing-induced atrial
arrhythmias were observed more frequently in Pitx2null+/−
(100%, six of six mice) than in WT mice (one of four mice,
Fisher’s exact test, P = 0.033). One of the Pitx2null+/− mice
showed an atrial arrhythmia only once with an episode lasting for
at least 16 s, whereas five of six Pitx2null+/− mice developed
arrhythmias following both burst-pacing stimuli. Mean duration
of atrial arrhythmias in Pitx2null+/− mice, confirmed by rapid and
regular a-wave on atrial electrograms, was 164 ± 131 s. In ad-
dition, we observed an episode of AFL/tachycardia in one of the
WT mice (although this episode only lasted 6.8 s). Taken to-
gether, our findings indicate that Pitx2c haploinsufficiency pre-
disposes mice to atrial arrhythmias, including AFL/tachycardia.
Fig. 1. Pitx2 is expressed in the left atrium and pul-
monary vein of postnatal mice. (A–G) Whole-mount
LacZ staining and sagittal sections of Pitx2 LacZ allele
at P3. Pitx2 is expressed in the left atrium, right ven-
tricle, and pulmonary vein (arrows). Boxed areas in
D and F are shownat highermagnification in E andG,
respectively. (H–J) LacZ staining (arrows) on sagittal
sections of Pitx2 LacZ allele on P42 shows LacZ activity
in the left atrium. Boxed areas in H are shown at
higher magnification in I and J. (K–N) LacZ staining
(arrows) on sagittal sections of 1-year-old Pitx2 LacZ
allele. Pitx2 is expressed in rare left atrial myocardial
cells in left atrium. Boxed areas in K are shown at
highermagnification in L,M, andN. (Magnification in
E, G, I, J and L-N:×200.) (O) RT-PCR of Pitx2c inWT left
atrium and right atrium shows Pitx2c is expressed in
left atrium. (P) Quantitative RT-PCR analysis of Pitx2c
comparing embryonic and adult stages. Arrows in-
dicate Lac staining. *, statistically significant differ-
ence (P < 0.05). LA, left atrium; LV, left ventricle; PV,
pulmonary vein; RA, right atrium; RV, right ventricle.
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Pitx2c Inhibits the Pacemaker Gene Program in Left Atrium. To gain
insight into the mechanisms underlying predisposition to AFL/
tachycardia, we performed microarray analysis on Pitx2null-mu-
tant and control hearts (Methods and Fig. S3). Interestingly the
microarray study revealed that the SAN genes Shox2 and Tbx3,
as well as a number of channel genes, were up-regulated in the
Pitx2null-mutant embryos when compared with controls (Fig. 3A).
Among the up-regulated channel genes was Kcnq1, a potassium-
channel gene that has been implicated in familial AF through
a gain-of-function mutation (20).
We next used quantitative RT-PCR and whole-mount in situ
hybridization to gain further insight into the mechanisms un-
derlying predisposition to AFL/tachycardia in Pitx2cmutants. We
examined expression of Hcn4, a hyperpolarization-activated, cy-
clic nucleotide-gated (HCN) channel that has a critical role in
SAN automaticity (21, 22). In 12.5-dpc control embryos,Hcn4was
expressed in the large caval veins posterior to the heart, as well as
in the forming SAN region (Fig. 3Ca and Fig. S4 A and B). In
Pitx2null+/− mutants, Hcn4 appeared to be modestly up-regulated
in the left superior caval vein that also expresses Pitx2c (Fig. 3Cb
and Fig. S4 C andD) (23). In Pitx2null−/− embryos, the anatomy of
the junction between the large veins and the atrium was disrupted
(24, 25), and Hcn4 was expressed continuously in the abnormal
vein–atrial junction in Pitx2null−/−-mutant embryos and in the
posterior wall of the mutant left atrium (Fig. 3Cc and Fig. S4 E
and F). Quantitative RT-PCR indicated that Hcn4 was quantita-
tively up-regulated in both Pitx2null+/− and Pitx2null−/−mutant em-
bryos (Fig. 3B).
Tbx3 is a T-box gene that is expressed in SAN progenitors and
is required for correct separation of the SAN from working atrial
myocardium (26). In Pitx2null+/− mutants, Tbx3 expression was
more prominent in the left atrioventricular canal, whereas in
Pitx2null−/− mutants Tbx3 was expanded and up-regulated in the
left atrioventricular canal and in the midline cells at the base of
the common venous sinus (Fig. 3 B and C d–f).
Shox2, a homeodomain containing transcription factor
expressed in the developing SAN, has been shown recently to be
required for SAN development (27, 28). At both 12.5 and 13.5
dpc in Pitx2null+/− embryos, Shox2 was expressed similarly to
control SAN progenitors, although expression was up-regulated
in left superior caval vein and interatrial septum of Pitx2null+/−
embryos (Fig. 3C g, h, j, and k and Fig. S4 G–J and M–P). Shox2
up-regulation was confirmed using quantitative RT-PCR (Fig.
3B). In Pitx2null−/− embryos, Shox2 was expanded in the posterior
wall of the left atrium and left atrial myocardium (Fig. 3 C i and l
and Fig. S4 K, L, Q, and R). Quantitative RT-PCR also indicated
that Shox2 was up-regulated in Pitx2null−/− embryos (Fig. 3B).
In addition to genes identified in the microarray, we also in-
vestigated candidate genes in the Pitx2 mutants. Nppa, encoding
the atrial natriuretic peptide hormone that regulates in-
travascular volume, has been reported to be a Pitx2 target and
has been implicated in familial AF (29, 30). Whole-mount in situ
hybridization and quantitative RT-PCR indicated that Nppa
expression was up-regulated in Pitx2null+/− and Pitx2null−/−-
mutant embryos (Fig. 3 B and C m–o).
We next evaluated gene expression in the left atrium of P42
Pitx2null+/− mice that were prone to atrial arrhythmias as shown
in Fig. 2. Microarray analysis followed by quantitative RT-PCR
verification revealed that genes expanded in the adult heart were
similar to those up-regulated in Pitx2null-mutant embryos. A
number of potassium-channel genes, including Kcnq1, were up-
regulated in the Pitx2null+/− P42 left atrium, as well as the SAN
genes Shox2 and Hcn4 (Fig. 3 D and E).
Pitx2c Directly Represses Shox2. To understand the underlying
molecular mechanisms in the predisposition to atrial arrhythmia
in Pitx2null+/− mice, we generated an allele of Pitx2, Pitx2Flag (Fig.
4 A–C). We found that Pitx2Flag directed Pitx2c expression in
embryoid bodies cultured from 7–10 days (Fig. 4D). In the P0
heart, we observed strong expression of Pitx2c protein in mice
that were heterozygous for the Pitx2Flag allele (Fig. 4D).
Bioinformatics analysis revealed a Pitx2c recognition element
in the Shox2 gene that was conserved in the mouse, human, dog,
and cow genomes (Fig. 4E andMethods). Moreover, in vivo ChIP
indicated that the Pitx2c recognition element, located in Shox2
intron 2, was bound by Pitx2c in both embryoid bodies and the
adult left atrium (Fig. 4F). Transfection experiments using a 2-kb
Shox2 genomic fragment that included the Pitx2c binding site
indicated that Pitx2c repressed Shox2 expression in P19 cells and
that this repression was lost when the Pitx2c binding site was
mutated (Fig. 4G). Together, our findings support the hypothesis
that Shox2 is a direct target for Pitx2c repression in the embry-
onic and adult left atrium.
Discussion
Atrial arrhythmias such as AF and AFL are common human
arrhythmias with potentially devastating clinical consequences.
Our findings, taken together with previously reported data, in-
dicate that Pitx2c is an important susceptibility gene for atrial
arrhythmias that normally represses the pacemaker gene pro-
gram in the left atrium. We identify Shox2, a critical regulator of
the SAN gene program, as a Pitx2c target gene. The observation
Fig. 2. Surface ECG (A) and intracardiac electrograms (B and C) revealing an
episode of pacing-induced atrial tachycardia in a Pitx2null+/− mouse. (A)
Surface ECG showing the last three paced beats of the burst protocol. The
tracing reveals the absence of P waves and irregular RR intervals, suggestive
of atrial arrhythmia. (B) Atrial electrogram shows the presence of rapid and
regular a waves, suggestive of AFL/tachycardia. (C) Ventricular electrograms
reveals irregular intervals between v waves.
Table 1. Baseline cardiac electrophysiological parameters in WT
and Pitx2null+/− mice
ECG intervals (ms) WT (n = 4) Pitx2null+/− (n = 6) Statistics
HR 470.5 ± 36.3 487.8 ± 8.6 NS
RR 129.7 ± 9.4 123.2 ± 2.2 NS
PR 44.9 ± 1.3 46.1 ± 0.74 NS
QRS 9.1 ± 0.2 10.7 ± 0.4 P = 0.05
QTc 23.5 ± 1.2 26.8 ± 1.1 NS
SNRT 179.8 ± 31.0 176 ± 13.5 NS
AVERP 52.0 ± 2.2 56 ± 1.3 NS
AERP 44.5 ± 0.3 47.7 ± 1.4 NS
All values expressed mean ± SEM. AERP, atrial effective refractory period;
AVERP, atrioventricular nodal effective refractory period; HR, heart rate; NS,
nonsignificant; PR, interval from beginning of P waves to the peak of R wave;
QRS, duration of interval between beginning of Q wave to peak of S wave;
QTc, duration of Q-T interval corrected for heart rate; RR, interval between
two consecutive R wave peaks; SNRT, sinus node recovery time.
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that Pitx2c is most highly expressed during embryogenesis and in
the early postnatal heart suggests that the arrhythmogenic sub-
strate is established relatively early in life.
Pitx2c Directly Inhibits Pacemaker Specification. Our in vivo ChIP
data and transfection experiments indicate that Pitx2c normally
silences Shox2 in the left atrium. Previous work has shown that
Fig. 3. Pitx2 inhibits the SAN program. (A). Heat map of microarray data from Pitx2null−/−-mutant embryo hearts compared with WT hearts at 13.5 dpc. All
pacemaker genes and ion-channel genes designated to be present at significant levels were identified in the normalized data, followed by log2 trans-
formation, subjected to hierarchical clustering and heat-map generating. (B) Quantitative RT-PCR validation of microarray analysis of Pitx2-mutant hearts
compared with WT control hearts at 13.5 dpc. The quantitative real-time RT-PCR analysis showed that Kcnq1, ANF, Hcn4, Shox2, and Tbx3 were up-regulated
in Pitx2-mutant hearts. (C). Whole-mount in situ analysis at 12.5 dpc and 13.5 dpc with indicated probes. Genotypes and probes are labeled. Arrows designate
areas of relevant gene expression in control and mutant embryos. (D) Heat map of microarray data and (E) quantitative RT-PCR validation of microarray on
WT and Pitx2null+/− mouse hearts at P42. Potassium-channel genes including Kcnq1, as well as the SAN genes Shox2 and Hcn4, were up-regulated in the
Pitx2null+/−-mutant hearts. In B and E, * indicates statistically significant differences (P < 0.05).
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Shox2-mutant mice have defective SAN development with re-
duced expression of Hcn4 and Tbx3, indicating that Shox2 posi-
tively regulates the SAN genetic program. Shox2 functions, at
least in part, by inhibiting Nkx2.5 expression in SAN progenitors
(Fig. S5) (27, 28). Nkx2.5 promotes the atrial working myocardial
program and represses the SAN genetic pathway (31, 32).
Transfection experiments revealed that Shox2 directly represses
the Nkx2.5 5′ flanking region and that this repression was in-
dependent of Shox2 DNA binding activity (28). Although this
genetic program is intact on the right side of the embryo, on the
left side Pitx2c disrupts the negative cascade by inhibiting Shox2
expression (Fig. S5).
Tbx3 also promotes the SAN phenotype while inhibiting the
working atrial myocardial phenotype through both direct and
indirect mechanisms. There is strong evidence that Tbx3 binds to
and inhibits atrial genes, such as Cx43. Tbx3 also promotes the
expression of SAN genes, most likely through a poorly understood
indirect mechanism (26). Moreover, recent findings indicate that
Tbx3 is genetically downstream of Shox2 (28). Together, our data
support a model whereby Pitx2c directly represses Shox2 and
inhibits the SAN genetic program in left atrium.
Our findings support the notion that Pitx2c loss of function
promotes ectopic automaticity in the left atrium. Under normal
conditions, the left atrium should be protected from impulse
generation. In Pitx2null+/− mutants, our data reveal that left atrial
myocardium expresses genes that are characteristic of the SAN
such as Hcn4. We suggest that the Pitx2null+/− null mutant left
atrium provides an arrhythmogenic substrate that would enhance
other pathologic triggers for atrial arrhythmias.
Atrial Fibrillation and Left–Right Asymmetry: A Direct Molecular
Connection. Our findings indicate that the Pitx2c-mediated LRA
signaling cascade inhibits SAN specification by disrupting a neg-
ative regulatory transcriptional cascade. Previous work showed
that Pitx2c directs formation of left and right anatomic charac-
teristics that separate the systemic and pulmonic circulation that
is vital for normal cardiac function. Morphologic abnormalities
in Pitx2null homozygous mutants include right atrial isomerism
with bilateral venous valves, deficiency of the primary interatrial
septum, and anomalous pulmonary venous drainage (31, 33). In
Pitx2c−/−-mutant embryos, caval and pulmonary veins drain into
an abnormal medial venous sinus. Moreover, there was a de-
ficiency in contribution of the Pitx2-expressing lineage to pul-
monary veins in Pitx2c homozygous mutant embryos (25)
because of a defect in pulmonary vein precursors (24).
Mommersteeg and colleagues (31) reported that Pitx2c ho-
mozygous mutants had a bilateral SAN that expressed SAN
markers such as Hcn4. Our findings suggest that Pitx2c regulates
the precise location of the SAN by directly inhibiting Shox2,
a transcriptional regulator of SAN gene program. Moreover, we
show that Pitx2 haploinsufficiency promotes the occurrence of
atrial tachyarrhythmias.
Our data uncover a remarkably close connection between
LRA and the SAN genetic program. Pitx2c is a direct target of
the TGFβ superfamily member Nodal that is expressed tran-
siently at early stages of development (10). Left-sided Pitx2c
expression persists in organ primordia well after Nodal has been
silenced (34, 35). Furthermore, the identification of Pitx2c as
a susceptibility gene for atrial arrhythmias provides deeper in-
sight into the genetic pathways that predispose to AF and AFL.
Importantly, the Nodal-Pitx2c signaling cassette is evolutionarily
conserved, raising the possibility that Nodal also is implicated in
predisposition to atrial arrhythmias. Indeed, mutations in Nodal
have been identified in human patients with LRA defects but
have not been reported in familial AF (36).
Other Mechanisms Contributing to Pitx2c Predisposition to Atrial
Arrhythmia. In addition to the Shox2-mediated mechanism, we
found other gene expression changes in Pitx2c mutants that sug-
gest other contributory mechanisms for predisposition to atrial
arrhythmias. Atrial natriuretic peptide, encoded by Nppa, regu-
lates multiple ion channels in atrial cardiomyocytes. An atrial
natriuretic peptide gain-of-function mutation that may promote
arrhythmias within atrial myocardium has been identified in hu-
man patients (29). Our finding that Nppa was up-regulated in
Fig. 4. Pitx2 directly represses Shox2.
(A) Summary of exon usage by Pitx2
isoforms. AUG and UGA: start and stop
codons; E1->E6, exons 1->6. (B) Target-
ing strategy of generating the Pitx2Flag
allele. (C) Southern blots for the Pitx2Flag
allele showing the WT 7-kb and mutant
4-kb bands. (D) Western blot showed
Pitx2Flag-directed Pitx2 expression in
embryoid bodies and P0 heart. D7-D10,
culture day 7–10. (E) Alignment of Pitx2
recognition elements in Shox2. (F) In
vivo ChIP indicated that Shox2 was
bound by Pitx2 in embryoid bodies (EB)
and adult left atrium (H). (G) Luciferase
activity assay experiments indicated that
Pitx2 repressed Shox2 in P19 cells and
that this repression was lost when the
Pitx2 binding site was mutated. At top,
highlight in red indicates point mutation
inserted to disrupt Pitx2 binding. * indi-
cates statistically significant differences
(P < 0.05).
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Pitx2c mutants suggests that similar mechanisms may contribute
to the predisposition to atrial arrhythmia in Pitx2c mutants.
Previous work indicated that a gain-of-function substitution in
a conserved serine of Kcnq1 (S140G) results in familial AF (20).
Moreover, separate mutations in Kcnq1—a serine-to-proline
(S209P) substitution and a valine-to-methionine (V141M) sub-
stitution—also were reported in familial AF (37, 38). In vitro
experiments indicate that the gain-of-function mutations in
Kcnq1may be caused by defects in channel inactivation (39). Our
data indicate that Kcnq1 is up-regulated in Pitx2c mutants. To-
gether these findings suggest that Pitx2c likely has multiple tar-
gets that are relevant to the predisposition to atrial arrhythmia.
Methods
Mouse Alleles and Transgenic Lines. The Pitx2null allele, which removes func-
tion of all Pitx2 isoforms, and the Pitx2tg3k transgenic line have been de-
scribed previously (15, 16).
Real-Time Quantitative PCR. Total RNA was isolated from embryonic hearts
and adult hearts using RNeasy Micro Kit (QIAGEN), followed by RT-PCR using
Super ScriptTM II reverse transcriptase (Invitrogen). Real-time thermal cycling
was performed using Mx3000P thermal cycler (Stratagene) with SYBR Green
JumpStartTM Taq ReadyMixTM (Sigma). Sequences of primers are available
upon request.
Cardiac Electrophysiology. Cardiac electrophysiology was performed as de-
scribed (40).
Microarray Studies. Total RNA was extracted from embryonic hearts or P42
hearts and purified using either RNeasy Micro Kit (QIAGEN) for embryonic
hearts or TRIzol Reagent (Invitrogen) for postnatal hearts. DNA microarray
analysis was performed using the OneArray Mouse Whole Genome Array
that interrogated 17,455 unique genes using 29,972 probes (Phalanx Biotech
Group). Graphical presentations of the array data are shown in Fig S3.
ChIP. ChIP analysis was performed using a ChIP assay kit (Upstate).
Generation of Reporter Constructs. Using rVista2.0 (41) and Ensembl genomic
alignments (http://www.ensembl.org/), we analyzed Shox2 genomic sequence
and the genomic sequence5 kb upstream of Shox2 to identify conserved Pitx2
binding sites.Thisanalysiswas followedby theChIPanalysis, and thePitx2biding
site “TAATCC” in intron between exon 2 and exon3 of Shox2was validated.
Site-Directed Mutagenesis. Site-directed mutagenesis of the Pitx2 binding
sites in the Shox2 intron was achieved by using the QuikChange II site-di-
rected mutagenesis kit (Stratagene).
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